CoChat

PYY plays a key role in the resolution of diabetes following bariatric surgery in humans

Open access
Guida, Claudia, Stephen, Sam D., Watson, Michael, Dempster, Niall, Larraufie, Pierre, Marjot, Thomas, Cargill, Tamsin, Rickers, Lisa, Pavlides, Michael, Tomlinson, Jeremy, Cobbold, Jeremy F.L., Zhao, Chun-Mei, Chen, Duan, Gribble, Fiona, Reimann, Frank, Gillies, Richard, Sgromo, Bruno, Rorsman, Patrik, Ryan, John D., Ramracheya, Reshma D. · 2019 · EBioMedicine
Cited by 97

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Bariatric surgery leads to early and long-lasting remission of type 2 diabetes (T2D). However, the mechanisms behind this phenomenon remain unclear. Among several factors, gut hormones are thought to be crucial mediators of this effect. Unlike GLP-1, the role of the hormone peptide tyrosine tyrosine (PYY) in bariatric surgery in humans has been limited to appetite regulation and its impact on pancreatic islet secretory function and glucose metabolism remains under-studied. METHODS: Changes in PYY concentrations were examined in obese patients after bariatric surgery and compared to healthy controls. Human pancreatic islet function was tested upon treatment with sera from patients before and after the surgery, in presence or absence of PYY. Alterations in intra-islet PYY release and insulin secretion were analysed after stimulation with short chain fatty acids (SCFAs), bile acids and the cytokine IL-22. FINDINGS: We demonstrate that PYY is a key effector of the early recovery of impaired glucose-mediated insulin and glucagon secretion in bariatric surgery. We establish that the short chain fatty acid propionate and bile acids, which are elevated after surgery, can trigger PYY release not only from enteroendocrine cells but also from human pancreatic islets. In addition, we identify IL-22 as a new factor which is modulated by bariatric surgery in humans and which directly regulates PYY expression and release. INTERPRETATION: This study shows that some major metabolic benefits of bariatric surgery can be emulated ex vivo. Our findings are expected to have a direct impact on the development of new non-surgical therapy for T2D correction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2018.12.040

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Holst, 2016, Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor, Surg Obes Relat Dis, 12, 1236, 10.1016/j.soard.2016.02.033 · DOI · Paper page
  2. Mokadem, 2014, Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency, Mol Metab, 3, 191, 10.1016/j.molmet.2013.11.010 · DOI · Paper page
  3. Wilson-Perez, 2013, Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency, Diabetes, 62, 2380, 10.2337/db12-1498 · DOI · Paper page
  4. Pournaras, 2010, The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study, Obes Surg, 20, 56, 10.1007/s11695-009-9989-1 · DOI
  5. Clements, 2004, Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus, Am Surg, 70, 1, 10.1177/000313480407000101 · DOI · Paper page
  6. Rubino, 2004, The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism, Ann Surg, 240, 236, 10.1097/01.sla.0000133117.12646.48 · DOI · Paper page
  7. Ramracheya, 2016, PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery, Cell Rep, 15, 944, 10.1016/j.celrep.2016.03.091 · DOI · Paper page
  8. Karamanakos, 2008, Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study, Ann Surg, 247, 401, 10.1097/SLA.0b013e318156f012 · DOI · Paper page
  9. Peterli, 2009, Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial, Ann Surg, 250, 234, 10.1097/SLA.0b013e3181ae32e3 · DOI · Paper page
  10. Papamargaritis, 2013, Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy, Surg Obes Relat Dis, 9, 192, 10.1016/j.soard.2012.08.007 · DOI
  11. Federico, 2016, Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: effect of bariatric surgery, In Vivo, 30, 321
  12. Guida, 2018, Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY, Diabetes Obes Metab, 20, 571, 10.1111/dom.13113 · DOI
  13. Bhutta, 2015, Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats, PLoS One, 10, 10.1371/journal.pone.0122273 · DOI · Paper page
  14. Larraufie, 2017, TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways, Cell Microbiol, 19, 10.1111/cmi.12648 · DOI · Paper page
  15. Viana, 2013, Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-alpha. Prospective clinical trial, Obes Surg, 23, 1252, 10.1007/s11695-013-0894-2 · DOI
  16. Miller, 2011, Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery, Surg Obes Relat Dis, 7, 618, 10.1016/j.soard.2011.03.006 · DOI · Paper page
  17. Wang, 2014, Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes, Nature, 514, 237, 10.1038/nature13564 · DOI · Paper page
  18. Hasnain, 2014, Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress, Nat Med, 20, 1417, 10.1038/nm.3705 · DOI · Paper page
  19. Lake, 1989, Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator, Diabetes, 38, 143, 10.2337/diab.38.1.S143 · DOI · Paper page
  20. Jorgensen, 2013, Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes, Diabetes, 62, 3044, 10.2337/db13-0022 · DOI · Paper page
  21. Psichas, 2017, Mixed primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells, JoVE, 122
  22. Ilhan, 2017, Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding, ISME J, 11, 2047, 10.1038/ismej.2017.71 · DOI · Paper page
  23. Psichas, 2015, The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents, Int J Obes (Lond), 7, 424, 10.1038/ijo.2014.153 · DOI · Paper page
  24. Pingitore, 2017, The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro, Diabetes Obes Metab, 19, 257, 10.1111/dom.12811 · DOI · Paper page
  25. Bala, 2014, Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-epsilon pathway and modulated by endogenous H2S, Front Physiol, 5, 420, 10.3389/fphys.2014.00420 · DOI · Paper page
  26. Sabat, 2015, Deciphering the role of interleukin-22 in metabolic alterations, Cell Biosci, 5, 68, 10.1186/s13578-015-0060-8 · DOI
  27. Shioya, 2008, Interleukin 22 receptor 1 expression in pancreas islets, Pancreas, 36, 197, 10.1097/MPA.0b013e3181594258 · DOI
  28. Murphy, 2016, Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol, BMJ Open, 6, 10.1136/bmjopen-2016-011416 · DOI
  29. Major, 2015, Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity, Wideochir Inne Tech Maloinwazyjne, 10, 458
  30. Nannipieri, 2013, Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones, J Clin Endocrinol Metab, 98, 4391, 10.1210/jc.2013-2538 · DOI · Paper page
  31. Guo, 2018, Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery, Eur J Endocrinol, 178, 43, 10.1530/EJE-17-0403 · DOI · Paper page
  32. Lin, 2012, Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms, PLoS One, 7, 10.1371/journal.pone.0035240 · DOI · Paper page
  33. Prawitt, 2011, Bile acid metabolism and the pathogenesis of type 2 diabetes, Curr Diab Rep, 11, 160, 10.1007/s11892-011-0187-x · DOI · Paper page
  34. Renga, 2010, The bile acid sensor FXR regulates insulin transcription and secretion, Biochim Biophys Acta, 1802, 363, 10.1016/j.bbadis.2010.01.002 · DOI · Paper page
  35. Richette, 2011, Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis, Ann Rheum Dis, 70, 139, 10.1136/ard.2010.134015 · DOI · Paper page
  36. Chacon, 2008, Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro, Int J Obes (Lond), 32, 1122, 10.1038/ijo.2008.40 · DOI
  37. Stolberg, 2018, Effects of gastric bypass surgery followed by supervised physical training on inflammation and endothelial function: a randomized controlled trial, Atherosclerosis, 273, 37, 10.1016/j.atherosclerosis.2018.04.002 · DOI · Paper page
  38. Yang L, Zhang Y, Wang L, Fan F, Zhu L, Li Z, et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 2010;53(2):339–47. · DOI · Paper page
  39. Nostedt, 2016, The effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease, Can J Gastroenterol Hepatol, 2016, 2059245, 10.1155/2016/2059245 · DOI

Cited by

See all 97

Metadata

Authors
Guida, C., Stephen, S. D., Watson, M., Dempster, N., Larraufie, P., Marjot, T., Cargill, T., Rickers, L., Pavlides, M., Tomlinson, J., Cobbold, J. F. L., Zhao, C.-M., Chen, D., Gribble, F., Reimann, F., Gillies, R., Sgromo, B., Rorsman, P., Ryan, J. D., & Ramracheya, R. D.
Venue
EBioMedicine
Publisher
Elsevier BV
Published
2019-02
Volume
40
Pages
67-76
ISSN
2352-3964 (ISSN-L)
OpenAlex
W2911185744
Cited by
97
References
15
FWCI
10.15
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Novo Nordisk
  • Norges Teknisk-Naturvitenskapelige Universitet
  • Vetenskapsrådet
  • National Institute for Health and Care Research
  • European Association for the Study of the Liver
  • St. Olavs Hospital Universitetssykehuset i Trondheim
  • Diabetes UK

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.